Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 23, Issue 16, pp. 4693-4703
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 31, 2017
- Revision received March 14, 2017
- Accepted April 21, 2017
- Published first April 26, 2017.
Article Versions
- Previous version (April 26, 2017 - 09:51).
- Previous version (June 27, 2017 - 06:46).
- You are viewing the most recent version of this article.
Copyright & Usage
©2017 American Association for Cancer Research.
Author Information
- Liana B. Guedes1,
- Fawaz Almutairi1,
- Michael C. Haffner1,
- Gaurav Rajoria2,
- Zach Liu2,
- Szczepan Klimek2,
- Roberto Zoino2,
- Kasra Yousefi3,
- Rajni Sharma1,
- Angelo M. De Marzo1,4,5,
- George J. Netto1,
- William B. Isaacs4,5,
- Ashley E. Ross4,
- Edward M. Schaeffer4, and
- Tamara L. Lotan1,5,*
- 1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- 2Pathline Emerge Pathology Services, Ramsey, New Jersey.
- 3GenomeDx Biosciences, Vancouver, British Columbia.
- 4Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- 5Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- ↵*Corresponding Author:
Tamara L. Lotan, Johns Hopkins University School of Medicine, CRB II Rm 343, 1550 Orleans Street, Baltimore, MD 21231. Phone: 410-614-9196; Fax: 410-614-0671; E-mail: tlotan1{at}jhmi.edu
August 2017
Volume 23, Issue 16
Volume 23, Issue 16
Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of TP53 Missense Mutation in Prostate Cancer
Jump to section
Advertisement